Dr. Filippo Milano

For the Media

Dr. Filippo Milano

Dr. Filippo Milano is an assistant member of Fred Hutch's Clinical Research Division and associate director of Fred Hutch's Cord Blood Program. His research is focused on the use of umbilical cord blood transplantation as source of stem cells. In particular, he has focused my research on clinical practice improvements with the goal to increase the number of patients eligible to be recipients and to improve clinical outcomes for patients undergoing cord blood transplantation.

Resources for more information

  • Overview of Filippo Milano’s Research
    Dr. Milano's research is focused on improving the outcomes for cord blood transplant recipients.  
  • Filippo Milano – Seattle Cancer Care Alliance profile
    Dr. Filippo Milano is the associate director of the Cord Blood Transplant Program and treats patients with acute leukemias and other blood disorders
  • The Delaney Lab
    Laboratory and clinical research components of the Cord Blood Program, led by Dr. Delaney, are focused on the development of revolutionary techniques for improving outcomes from transplantation and changing the standards of care to help prevent infection and speed recovery after transplant or chemotherapy.  This is being done by harnessing cord blood's lifesaving power.
  • Cord Blood Program
    Program researchers continue to develop ways to make immunity-boosting therapies even more effective. They are showing these treatments can induce remissions for patients with advanced tumors and are likely to have broad utility across many cancers. 


Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.


Photos / Graphics / Video


Download photos and view video ofFilippo Milano

Related Stories

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.